Organoid Cultures Derived from Patients with Advanced Prostate Cancer
NormalizedRLU
A
NormalizedTumorVolume
MSK-PCa1MSK-PCa2MSK-PCa3MSK-PCa4MSK-PCa5MSK-PCa6
D
MSK-PCa1
Figure6.SensitivitytoARandPI3KInhibitorinOrganoidLinesInVitroandInVivo
(A–C)Dose-responsecurvesoforganoidlinestoenzalutamide,everolimus,andBKM120.Growthwasmeasuredinquadrupletandviabilitywasas-sayed4daysaftertreatmentattheindicateddrugconcentrations(mean±SD).
(D–E)GrowthofMSK-PCA1andMSK-PCA2xe-nografts.Treatmentwasstartedwithtumorsreachanaveragesizeof400mm3.Eachtumorwasnormalizedtothepretreatmentsize.(n=10,mean±SEM).pvaluederivedfromunpairedtwo-tailedttestofnormalizedtumorsizeattheendoftreatment.Ev:everolimus,Enz:enzalutamide,Cast:castration.
1
Enzalutamide(nM)
101001000
MSK-PCa1MSK-PCa2MSK-PCa3MSK-PCa4MSK-PCa5MSK-PCa6
NormalizedRLU
B
Time(weeks)
E



NormalizedTumorVolume
0.01
MSK-PCa2

Everolimus(nM)
0.1110100
(18bone,9lymphnode,2liver,1brain,1bladder,and1pleuraleffusion)and17bloodfrompatientswithhighCTCcount>100cellsper10mlofblood.
PleaseseeExtendedExperimentalProceduresfor
clinicaldetailsofthesevenorganoidlines.Allpatientsprovidedinformedconsentandsam-pleswereprocuredandthestudywasconducted0.010.1110Time(weeks)underMemorialSloan-KetteringCancerCenter
BKM120(µM)InstitutionalReviewBoardapproval(MSKCCIRB
90-040or06-107)priortotissueacquisition.Clin-icalandpathologicdatawereenteredandmain-practiceshouldincreasetheopportunitytogeneratemoreorga-tainedinadatabasebyourresearchprojectcoordinatorwhogeneratedanoidlinesandmayallowcharacterizationoftumorgenomesseparateanonymizeddatabaseforinvestigators.Metastaticprostatecancerfrombiopsymaterialwithtoofewtumorcellsfordirectanalysisbiopsypiecesweremincedanddigestedin5mlof5mg/mlcollagenase
typeII(Invitrogen)inAdvancedDMEM/F12(ADMEM/F12)anddigestedfor
(e.g.,MSK-PCa1,MSK-PCa2,andCTCsampleMSK-PCa5).
0.5–2hrat37 Cwithgentlyshaking.Dissociatedcellswerewashedand
Underselectionpressurefromtreatment,CRPCisahighlyseededingrowthfactorreducedMatrigel(BDbiosciences).heterogeneousdisease.ThewidespreaduseofincreasinglyForisolationofCTC,8mlofbloodsampleswasdrawnintoaheparintubeat
MemorialSloan-KetteringCancerCenter.Bloodwasincubatedwith400mlmoreef caciousARpathwayinhibitorsmayfurthergenerate
multiplediscrepantresistancemechanisms.CRPCtumorcellsRosetteSepHumanCD45DepletionCocktail(StemCellTechnologies)formayremaindependentonARorAR-likeactivity,ortheymay20minatroomtemperature,thendepletedoftheredbloodcellandwhite
bloodcellusingFicoll-Paque(GE).Isolatedcirculatingtumorcellswere
dedifferentiateintoAR-independentcells(Aroraetal.,2013;Bal-washedandseededingrowthfactorreducedMatrigel(BD

biosciences).
basetal.,2013;Beltranetal.,2011;Carveretal.,2011;ChenHumanprostatecancerorganoidswerepassagedeitherviatriturationwithaetal.,2013).TheCRPCorganoidlinesdescribedherealreadyglassPasteurpipetordissociationwithTrypLE(Sigma-Aldrich)for5minatdisplayabroadspectrumofARlevelsaswellasARtranscrip-37 C.Passagewasperformedweeklywitha1:3ratio.
NormalizedRLU
C

MSK-PCa1MSK-PCa2MSK-PCa3MSK-PCa4MSK-PCa5MSK-PCa6
tionalactivity.Thegenerationofmorelineswithde nedtreat-menthistoriesshouldaccelerateourmechanisticunderstandingofmoleculardeterminantsofsensitivity.
Prostatecancersharborseveraldisease-speci cmutations,includingETS-translocations,SPOPmutations,FOXA1muta-tions,andCHD1loss.Wehavegeneratedmodelsofeachoftheseprostate-speci calterationsandanticipatethatmorewillbegeneratedinthenearfuture.Additionally,CRPCorganoidsprovideanopportunitytode negeneticlesionsthatmediateprogressiontometastaticCRPC.ThehighfrequencyofRBandTP53pathwaydysfunctionintheCRPCorganoidlinessug-geststhatdrugstargetingthesepathwaysshouldbecomeatherapeuticpriority.
EXPERIMENTALPROCEDURES
IsolationandCultureofMetastaticProstateCancerCellsandCirculatingTumorCells
BetweenDecember2012toNovember2013,wecollected32metastasissam-pleswithdocumentedtumorcontent>10%ofthecellsonpathologyreview
RNA-SequencingandAnalysis
RNAwasisolatedfromorganoidswithlowpassagenumber(lessthan5)usingQIAGENRNeasykits.LibrarypreparationandRNAsequencingwasper-formedbyMSKCCGenomicsCoreLaboratoryusingIlluminaHiSeqwith50or75bppaired-endreads,and 30millionreadsweregeneratedforeachsample.Thereadsweremappedhumangenomereferencesequence(GRC37/hg19)usingSTAR(ver2.3)(Dobinetal.,2013)andquanti edintoRPKMusingCuf inkswithupperquartilenormalization(ver2.1)(Robertsetal.,2011).HeatmapsandclusteringanalysisusingPearsonCorrelationweregeneratedusingGENE-E(doc.guandang.net).RepresentativeregionsaredisplayedusingIntegratedGenomicsViewer(IGV,doc.guandang.net).
DNAExtraction,QualityControlLibraryPreparation
DNAfromtheseventumororganoidsampleswasextractedusingNucleospintissueXS(Clontech)accordingtomanufacturersprotocolforculturedcells.ThebuffycoatDNAofthecasesexceptMSK-PCa2wasextractedusingNu-cleospintissueXS(Clontech)accordingtomanufacturersprotocolforbloodsamples.PromegaMaxwell16systemwasusedtoextractedDNAfreshfrozentissue.MSK-PCa2normalDNAwasextractedfrom5FFPEtissuecurlsusingPromegaMaxwellFFPEPlusLEVsystem.
Cell159,1–12,September25,2014ª2014ElsevierInc.9
from patients with advanced prostate, bladder, or breast cancer as well as...Regardless of whether the peptidome is derived from the tissue/microenvironment...
[6], advanced melanoma [11], prostate cancer [...from healthy donors and from patients with chronic...In DC cultures of four healthy donors, Freezing ...
热门文档